Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully ...

Antibody discovery, crucial for developing targeted therapies in fields like oncology and autoimmune diseases, is evolving ...

Researchers show that analyzing the 3D shapes of antibodies, not just their genetic sequences, can better group functionally ...

Dose escalation of KY-0118, PD-1, and IL-2v due-target fusion protein in patients with advanced renal clear cell carcinoma, urothelial carcinoma, and malignant melanoma. This is an ASCO Meeting ...

Creative Diagnostics has released T7 RNA Polymerase ELISA Kits for the detection and quantitative determination of T7 RNA Polymerase. NEW YORK, NY, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- ...

Autoimmune diseases develop when the immune system mistakenly attacks the body’s own tissues by recognizing self-antigens as ...

Diversity training is more effective when it’s personalized, according to my new research in the peer-reviewed journal Applied Psychology. We found that this personalized approach worked ...

Procedures for CD4 lymphocyte depletion experiment, kinetics study of antibody generation, inhibition of Tn binding experiments and procedures for carbohydrate microarray studies. Supplementary ...

Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL). Impact of ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. The Harvard University logo is displayed on a ...

The vaccine successfully triggered VRC01-class responses in 94% of participants, showing similarly high levels of antibody mutation and diversity as seen in G002. Although one participant didn't ...